Why Apyx Medical APYX Just Dropped 688 What to Watch 20260515 Inside Scale AIs Business After Metas Bombshell 14 Billion Deal Elon Musk Faces Another Legal Setback in OpenAI Lawsuit Q4 Earnings Season Heats Up ITC Hotels Alembic Pharma Tata Steel Among Major Reporters on May 15 General Motors Reveals AllElectric Cadillac Vistiq with 300Mile Range Amgen Releases Q1 2026 Earnings Highlights Tech Stocks Rally Continues as AI Sector Leads IPO Revival QXO Inc Reports Robust Q1 Growth and Strategic Capital Raises Positioning for LongTerm Expansion Consumer Sentiment Plummets to Record Low in May as Inflation Fears Mount Amid Iran Conflict 12 Information Technology Stocks Moving In Tuesdays AfterMarket Session Titan Machinery Inc TITN Q1 2026 Earnings Significant EPS Miss Signals Continued Headwinds in Agriculture Sector TLK Q4 2025 Earnings EPS Misses Estimations Significantly Stock Declines 472 FOXA Q1 2026 Earnings EPS Surges Past Estimates with 339 Beat NBN Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Decline FBRX Q1 2026 Earnings WiderthanExpected Loss Reflects PreRevenue Biotech Reality XPER Q1 2026 Earnings Earnings Surge on Strong EPS Beat Allspring Utilities and High Income Fund ERH Holds Steady Near Resistance Despite Minor Dip Biohaven BHVN Surges 12 on Strong Volume Testing Key Resistance Savers Value Village SVV Edges Higher as Value Retail Navigates Consumer Caution Revolution Medicines Inc RVMD Slips Slightly Amid Sector Rotation Key Support Levels Tested Oak Woods Acquisition Corporation OAKU Holds Steady Amid Narrow Trading Range UL Solutions Holds Steady Near 100 as Consolidation Continues CODI Q1 2026 Earnings Stunning EPS Beat Masks Broader Market Concerns CRNT Q1 2026 Earnings EPS Beats Estimates Stock Rises SSBI Q1 2026 Earnings EPS of 025 Reported Stock Gains Slightly YSG Q4 2025 Earnings Positive EPS but Revenue Transparency Remains Limited OTLK Q1 2026 Earnings EPS Misses Estimates Amid PreCommercial Stage Stock Surges on Pipeline Optimism Evercore ISI Adjusts Outlook for Illinois Tool Works Price Target Revised Lower MGX Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline Nutrien Ltd NTR Holds Steady Above 70 on Modest Gains Key Resistance in Sight